Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David O Arnar

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Nature Genetics|January 12, 2010
Several common variants modulate heart rate, PR interval and QRS durationHilma Holm, Daniel F Gudbjartsson, David O Arnar, et al.
Journal of the American College of Cardiology|October 21, 2017
A Missense Variant in PLEC Increases Risk of Atrial FibrillationRosa B Thorolfsdottir, Gardar Sveinbjornsson, Patrick Sulem, et al.
European Heart Journal|March 29, 2018
A rare missense mutation in MYH6 associates with non-syndromic coarctation of the aortaThorsteinn Bjornsson, Rosa B Thorolfsdottir, Gardar Sveinbjornsson, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 19, 2019
Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS)David O Arnar, Georges H Mairesse, Giuseppe Boriani, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 3, 2010
EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapyLuigi Padeletti, David O Arnar, Lorenzo Boncinelli, et al.
Nature Genetics|July 20, 2021
Distinction between the effects of parental and fetal genomes on fetal growthThorhildur Juliusdottir, Valgerdur Steinthorsdottir, Lilja Stefansdottir, et al.
Journal of the American Heart Association|July 14, 2023
Screening for Rare Coding Variants That Associate With the QTc Interval in IcelandGardar Sveinbjornsson, Bara D Benediktsdottir, Gunnlaugur Sigfusson, et al.
Nature Communications|October 24, 2019
Sequence variants with large effects on cardiac electrophysiology and diseaseKristjan Norland, Gardar Sveinbjornsson, Rosa B Thorolfsdottir, et al.
European Heart Journal|October 16, 2016
A frameshift deletion in the sarcomere gene MYL4 causes early-onset familial atrial fibrillationDaniel F Gudbjartsson, Hilma Holm, Patrick Sulem, et al.
JAMA|May 12, 2005
Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trialHakon Hakonarson, Sverrir Thorvaldsson, Anna Helgadottir, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Nature Genetics|January 12, 2010
Several common variants modulate heart rate, PR interval and QRS durationHilma Holm, Daniel F Gudbjartsson, David O Arnar, et al.
Journal of the American College of Cardiology|October 21, 2017
A Missense Variant in PLEC Increases Risk of Atrial FibrillationRosa B Thorolfsdottir, Gardar Sveinbjornsson, Patrick Sulem, et al.
European Heart Journal|March 29, 2018
A rare missense mutation in MYH6 associates with non-syndromic coarctation of the aortaThorsteinn Bjornsson, Rosa B Thorolfsdottir, Gardar Sveinbjornsson, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 19, 2019
Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS)David O Arnar, Georges H Mairesse, Giuseppe Boriani, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 3, 2010
EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapyLuigi Padeletti, David O Arnar, Lorenzo Boncinelli, et al.
Nature Genetics|July 20, 2021
Distinction between the effects of parental and fetal genomes on fetal growthThorhildur Juliusdottir, Valgerdur Steinthorsdottir, Lilja Stefansdottir, et al.
Journal of the American Heart Association|July 14, 2023
Screening for Rare Coding Variants That Associate With the QTc Interval in IcelandGardar Sveinbjornsson, Bara D Benediktsdottir, Gunnlaugur Sigfusson, et al.
Nature Communications|October 24, 2019
Sequence variants with large effects on cardiac electrophysiology and diseaseKristjan Norland, Gardar Sveinbjornsson, Rosa B Thorolfsdottir, et al.
European Heart Journal|October 16, 2016
A frameshift deletion in the sarcomere gene MYL4 causes early-onset familial atrial fibrillationDaniel F Gudbjartsson, Hilma Holm, Patrick Sulem, et al.
JAMA|May 12, 2005
Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trialHakon Hakonarson, Sverrir Thorvaldsson, Anna Helgadottir, et al.
Pageof 9